LIVIVO - Search results -

Search results

Result 1 - 10 of total 17

Search options

Article ; Online: A review on PUVA pricks-A debilitating adverse event.

Wyckmans, Martin / Bervoets, An

Photodermatology, photoimmunology & photomedicine

2022 Volume 39, Issue 3, Page(s) 185–192

Abstract: Purpose: PUVA phototherapy is indicated for various dermatological conditions. Adverse events due to PUVA phototherapy are seen in a sizable number of patients and can result in therapy cessation. This review will focus on PUVA pricks, an adverse event ... ...

Abstract	Purpose: PUVA phototherapy is indicated for various dermatological conditions. Adverse events due to PUVA phototherapy are seen in a sizable number of patients and can result in therapy cessation. This review will focus on PUVA pricks, an adverse event first reported by Tegner in 1979. Methods: Articles were retrieved from PubMed starting from January 1979 until February 2021 yielding 1228 unique articles. Articles were included when they described individual patient characteristics, and patients were treated with PUVA therapy. Results: After screening, 33 patients were extracted from 9 articles, published between 1979 and 2005. Conclusion: PUVA pricks are paroxysmal episodes of burning or prickling pain, akin to peripheral neuropathy of the unmyelinated C-fibers. Increased excitability of TRPV1 and TRPA1 channels while under PUVA therapy might be a contributing factor. Effective topical treatment options for PUVA pricks are capsaicin 8% cream, urea 4%, or petrolatum emollients. Antiepileptics such as phenytoin, clonazepam, and gabapentin are acceptable oral treatment options. A possible role of N-acetylcysteine in the prevention of PUVA pricks is discussed, though further research is required.
MeSH term(s)	Humans ; PUVA Therapy/adverse effects ; Emollients ; Petrolatum
Chemical Substances	Emollients ; Petrolatum (8009-03-8)
Language	English
Publishing date	2022-08-09
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	1028855-7
ISSN	1600-0781 ; 0108-9684 ; 0905-4383
ISSN (online)	1600-0781
ISSN	0108-9684 ; 0905-4383
DOI	10.1111/phpp.12824
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1951: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾

Article: Contact allergy mimicking trench foot infection: a case study.

De Leeuw, Jonas / Mertens, Michelle / Bervoets, An / Kate, Gerrit Luit Ten

Journal of wound care

2022 Volume 31, Issue 5, Page(s) 424–426

Abstract: Hard-to-heal wounds are a major cause of morbidity and/or mortality. Multiple aetiologies can be identified and wounds can be treated according to their aetiology and macroscopic appearance. However, evidence behind the wide range of locally applied ... ...

Abstract	Hard-to-heal wounds are a major cause of morbidity and/or mortality. Multiple aetiologies can be identified and wounds can be treated according to their aetiology and macroscopic appearance. However, evidence behind the wide range of locally applied treatments is weak, without clear guidelines available to treat a variety of wound aetiologies. We present the case of a 63-year-old male with hard-to-heal wounds not responding to standard topical treatment. No clear underlying aetiology could be found. Extensive contact allergies were diagnosed after multiple topical and systemic treatments had been applied. A full recovery was observed after stopping topical agents and treating the wounds with an alternative treatment based on epicutaneous test results.
MeSH term(s)	Administration, Topical ; Dermatitis, Allergic Contact/diagnosis ; Diagnosis, Differential ; Humans ; Immersion Foot/diagnosis ; Male ; Middle Aged ; Wound Healing ; Wounds and Injuries/drug therapy ; Wounds and Injuries/physiopathology
Language	English
Publishing date	2022-05-17
Publishing country	England
Document type	Case Reports
ZDB-ID	1353951-6
ISSN	0969-0700
ISSN	0969-0700
DOI	10.12968/jowc.2022.31.5.424
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 4572: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 4: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Polyhexamethylene biguanide in wound care products: a non-negligible cause of peri-ulcer dermatitis.

Bervoets, An / Aerts, Olivier

Contact dermatitis

2016 Volume 74, Issue 1, Page(s) 53–55

MeSH term(s)	Biguanides/adverse effects ; Dermatitis, Allergic Contact/diagnosis ; Dermatitis, Allergic Contact/etiology ; Disinfectants/adverse effects ; Female ; Humans ; Leg Ulcer/therapy ; Middle Aged
Chemical Substances	Biguanides ; Disinfectants ; polihexanide (322U039GMF)
Language	English
Publishing date	2016-01
Publishing country	England
Document type	Case Reports ; Journal Article
ZDB-ID	193121-0
ISSN	1600-0536 ; 0105-1873
ISSN (online)	1600-0536
ISSN	0105-1873
DOI	10.1111/cod.12469
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1116: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: The Challenges of Crizotinib Treatment in a Child With Anaplastic Large Cell Lymphoma.

Vanheeswijck, Liesbeth / Verlooy, Joris / Van de Vijver, Els / Bervoets, An / Balliauw, Katleen / Schepens, Tom / Norga, Koen / van Heerden, Jaques

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

2021 Volume 26, Issue 6, Page(s) 647–654

Abstract: Survival in cases involving childhood malignancy is reaching nearly 80% in high-income countries, yet cancer remains one of the leading disease-related causes of death in children. In adult oncology the role of targeted therapies is established, but ... ...

Abstract	Survival in cases involving childhood malignancy is reaching nearly 80% in high-income countries, yet cancer remains one of the leading disease-related causes of death in children. In adult oncology the role of targeted therapies is established, but information regarding the use of these therapies in children is limited, largely because targeted therapies were developed in the context of adult pathologies. The few pediatric reports regarding crizotinib, an anaplastic lymphoma kinase (ALK) inhibitor, seem promising. This case of an 8-year-old male with an ALK-positive anaplastic large cell lymphoma highlights the challenges of treating children with crizotinib. Our experience with crizotinib was more challenging than described in the limited pediatric reports. Not only was the tumor response poorer than described in the reports, but a substantial amount of side-effects and practical difficulties, such as the method of administration and dosing, made management challenging. Many challenges for the use of targeted therapy in pediatric care currently persist. The limited research in pediatric populations leaves uncertainty regarding efficacy and short- and long-term side effects as well as practical difficulties. Despite a clear underlying biological rationale for certain targeted therapies, their contribution toward improving the outcome of childhood cancer remains largely unclear.
Language	English
Publishing date	2021-08-16
Publishing country	United States
Document type	Journal Article
ZDB-ID	3028543-4
ISSN	1551-6776
ISSN	1551-6776
DOI	10.5863/1551-6776-26.6.647
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Almost Missed It! Photo-contact Allergy to Octocrylene in a Ketoprofen-sensitized Subject.

Aerts, Olivier / Goossens, An / Bervoets, An / Lambert, Julien

Dermatitis : contact, atopic, occupational, drug

2016 Volume 27, Issue 1, Page(s) 33–34

MeSH term(s)	Acrylates/immunology ; Adult ; Anti-Inflammatory Agents, Non-Steroidal/immunology ; Cellulitis/diagnosis ; Dermatitis, Photoallergic/diagnosis ; Dermatitis, Photoallergic/etiology ; Diagnostic Errors ; Drug Hypersensitivity/diagnosis ; Drug Hypersensitivity/etiology ; Female ; Humans ; Ketoprofen/analogs & derivatives ; Ketoprofen/immunology ; Patch Tests/methods ; Photosensitizing Agents/immunology ; Skin Diseases, Vesiculobullous/diagnosis ; Sunscreening Agents/adverse effects
Chemical Substances	Acrylates ; Anti-Inflammatory Agents, Non-Steroidal ; Photosensitizing Agents ; Sunscreening Agents ; ketoprofen topical gel ; octocrylene (5A68WGF6WM) ; Ketoprofen (90Y4QC304K)
Language	English
Publishing date	2016-01
Publishing country	United States
Document type	Case Reports ; Journal Article
ZDB-ID	2144723-8
ISSN	2162-5220 ; 1532-8163 ; 1710-3568
ISSN (online)	2162-5220 ; 1532-8163
ISSN	1710-3568
DOI	10.1097/DER.0000000000000156
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3680: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Unravelling the immune signature of herpes zoster: Insights into pathophysiology and the HLA risk profile.

Vandoren, Romi / Boeren, Marlies / Schippers, Jolien / Bartholomeus, Esther / Mullan, Kerry / Michels, Nele / Aerts, Olivier / Leysen, Julie / Bervoets, An / Lambert, Julien / Leuridan, Elke / Wens, Johan / Peeters, Karin / Emonds, Marie-Paule / Jansens, Hilde / Casanova, Jean-Laurent / Bastard, Paul / Suls, Arvid / Van Tendeloo, Viggo /

Ponsaerts, Peter / Delputte, Peter / Ogunjimi, Benson / Laukens, Kris / Meysman, Pieter

The Journal of infectious diseases

2024

Abstract: The varicella-zoster virus (VZV) infects over 95% of the population. VZV reactivation causes herpes zoster (HZ), known as shingles, primarily affecting the elderly and immunocompromised individuals. However, HZ can also occur in otherwise healthy ... ...

Abstract	The varicella-zoster virus (VZV) infects over 95% of the population. VZV reactivation causes herpes zoster (HZ), known as shingles, primarily affecting the elderly and immunocompromised individuals. However, HZ can also occur in otherwise healthy individuals. We analyzed the immune signature and risk profile in HZ patients using a genome-wide association study across different UK Biobank HZ cohorts. Additionally, we conducted one of the largest HZ HLA association studies to date, coupled with transcriptomic analysis of pathways underlying HZ susceptibility. Our findings highlight the significance of the MHC locus for HZ development, identifying five protective and four risk HLA alleles. This demonstrates that HZ susceptibility is largely governed by variations in the MHC. Furthermore, functional analyses revealed the upregulation of type I interferon and adaptive immune responses. These findings provide fresh molecular insights into the pathophysiology and the activation of innate and adaptive immune responses triggered by symptomatic VZV reactivation.
Language	English
Publishing date	2024-01-09
Publishing country	United States
Document type	Journal Article
ZDB-ID	3019-3
ISSN	1537-6613 ; 0022-1899
ISSN (online)	1537-6613
ISSN	0022-1899
DOI	10.1093/infdis/jiad609
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Uh II Zs.50: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 445: Show issues

Order via subito

Details ▾

Article ; Online: Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation.

Boeren, Marlies / de Vrij, Nicky / Ha, My K / Valkiers, Sebastiaan / Souquette, Aisha / Gielis, Sofie / Kuznetsova, Maria / Schippers, Jolien / Bartholomeus, Esther / Van den Bergh, Johan / Michels, Nele / Aerts, Olivier / Leysen, Julie / Bervoets, An / Lambert, Julien / Leuridan, Elke / Wens, Johan / Peeters, Karin / Emonds, Marie-Paule /

Elias, George / Vandamme, Niels / Jansens, Hilde / Adriaensen, Wim / Suls, Arvid / Vanhee, Stijn / Hens, Niel / Smits, Evelien / Van Damme, Pierre / Thomas, Paul G / Beutels, Philippe / Ponsaerts, Peter / Van Tendeloo, Viggo / Delputte, Peter / Laukens, Kris / Meysman, Pieter / Ogunjimi, Benson

Cell reports

2024 Volume 43, Issue 4, Page(s) 114062

Abstract: The role of T cell receptor (TCR) diversity in infectious disease susceptibility is not well understood. We use a systems immunology approach on three cohorts of herpes zoster (HZ) patients and controls to investigate whether TCR diversity against ... ...

Abstract	The role of T cell receptor (TCR) diversity in infectious disease susceptibility is not well understood. We use a systems immunology approach on three cohorts of herpes zoster (HZ) patients and controls to investigate whether TCR diversity against varicella-zoster virus (VZV) influences the risk of HZ. We show that CD4
MeSH term(s)	Humans ; Herpes Zoster/immunology ; Herpes Zoster/virology ; Receptors, Antigen, T-Cell/metabolism ; Receptors, Antigen, T-Cell/immunology ; Lymphocyte Activation/immunology ; Herpesvirus 3, Human/immunology ; Female ; Middle Aged ; Male ; CD4-Positive T-Lymphocytes/immunology ; Aged ; Adult ; Epitopes, T-Lymphocyte/immunology
Chemical Substances	Receptors, Antigen, T-Cell ; Epitopes, T-Lymphocyte
Language	English
Publishing date	2024-04-07
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
ZDB-ID	2649101-1
ISSN	2211-1247 ; 2211-1247
ISSN (online)	2211-1247
ISSN	2211-1247
DOI	10.1016/j.celrep.2024.114062
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome.

Staels, Frederik / Betrains, Albrecht / Woei-A-Jin, F J Sherida H / Boeckx, Nancy / Beckers, Marielle / Bervoets, An / Willemsen, Mathijs / Neerinckx, Barbara / Humblet-Baron, Stephanie / Blockmans, Daniel Engelbert / Vanderschueren, Steven / Schrijvers, Rik

Frontiers in immunology

2021 Volume 12, Page(s) 678927

Abstract: Recently, a novel disorder coined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome was identified in patients with adult-onset inflammatory syndromes, often accompanied by myelodysplastic syndrome1. All patients had myeloid ... ...

Abstract	Recently, a novel disorder coined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome was identified in patients with adult-onset inflammatory syndromes, often accompanied by myelodysplastic syndrome1. All patients had myeloid lineage-restricted somatic mutations in UBA1 affecting the Met41 residue of the protein and resulting in decreased cellular ubiquitylation activity and hyperinflammation. We here describe the clinical disease course of two VEXAS syndrome patients with somatic UBA1 mutations of which one with a mild phenotype characterized by recurrent rash and symmetric polyarthritis, and another who was initially diagnosed with idiopathic multicentric Castleman disease and developed macrophage activation syndrome as a complication of the VEXAS syndrome. The latter patients was treated with anti-IL6 therapy (siltuximab) leading to a resolution of systemic symptoms and reduction of transfusion requirements.
MeSH term(s)	Aged ; Biopsy ; DNA Mutational Analysis ; Disease Management ; Disease Progression ; Disease Susceptibility ; Genes, X-Linked ; Humans ; Macrophage Activation Syndrome/diagnosis ; Macrophage Activation Syndrome/etiology ; Male ; Mutation ; Pedigree ; Symptom Assessment ; Syndrome ; Ubiquitin-Activating Enzymes/genetics
Chemical Substances	UBA1 protein, human ; Ubiquitin-Activating Enzymes (EC 6.2.1.45)
Language	English
Publishing date	2021-04-23
Publishing country	Switzerland
Document type	Case Reports ; Research Support, Non-U.S. Gov't
ZDB-ID	2606827-8
ISSN	1664-3224 ; 1664-3224
ISSN (online)	1664-3224
ISSN	1664-3224
DOI	10.3389/fimmu.2021.678927
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Lanthanum: a safe phosphate binder.

Persy, Veerle P / Behets, Geert J / Bervoets, An R / De Broe, Marc E / D'Haese, Patrick C

Seminars in dialysis

2006 Volume 19, Issue 3, Page(s) 195–199

Abstract: Accumulation of inorganic phosphate due to renal functional impairment contributes to the increased cardiovascular mortality observed in dialysis patients. Phosphate plays a causative role in the development of vascular calcification in renal failure; ... ...

Abstract	Accumulation of inorganic phosphate due to renal functional impairment contributes to the increased cardiovascular mortality observed in dialysis patients. Phosphate plays a causative role in the development of vascular calcification in renal failure; treatment with calcium-based phosphate binders and vitamin D can further increase the Ca x PO(4) product and add to the risk of ectopic mineralization. The new generation of calcium-free phosphate binders, sevelamer and lanthanum, can control hyperphosphatemia without adding to the patients calcium load. In this article, the metabolism of lanthanum carbonate and its effects in bone, liver and brain are discussed. Although lanthanum is a metal cation its effects are not comparable to those of aluminum. Indeed, in clinical studies no toxic effects of lanthanum have been reported after up to four years of follow-up. The bioavailability of lanthanum is extremely low. The effects observed in bone are due to phosphate depletion, with no signs of direct bone toxicity yet observed in rats or humans. The liver is the main route of excretion for lanthanum carbonate, which can be localized in the lysosomes of hepatocytes. No lanthanum could be detected in brain tissue.
MeSH term(s)	Animals ; Biological Availability ; Bone and Bones/drug effects ; Bone and Bones/metabolism ; Brain/drug effects ; Brain/metabolism ; Calcinosis/drug therapy ; Calcinosis/metabolism ; Clinical Trials as Topic ; Hepatocytes/drug effects ; Hepatocytes/metabolism ; Humans ; Kidney Failure, Chronic/drug therapy ; Kidney Failure, Chronic/metabolism ; Lanthanum/metabolism ; Lanthanum/pharmacokinetics ; Liver/drug effects ; Liver/metabolism ; Phosphate-Binding Proteins/blood ; Phosphate-Binding Proteins/drug effects ; Phosphate-Binding Proteins/pharmacokinetics
Chemical Substances	Phosphate-Binding Proteins ; lanthanum carbonate (490D9F069T) ; Lanthanum (6I3K30563S)
Language	English
Publishing date	2006-05
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	1028193-9
ISSN	1525-139X ; 0894-0959
ISSN (online)	1525-139X
ISSN	0894-0959
DOI	10.1111/j.1525-139X.2006.00169.x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 2879: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure.

Bervoets, An R J / Behets, Geert J / Schryvers, Dominick / Roels, Frank / Yang, Zhang / Verberckmoes, Steven C / Damment, Stephen J P / Dauwe, Simonne / Mubiana, Valentine K / Blust, Ronny / De Broe, Marc E / D'Haese, Patrick C

Kidney international

2009 Volume 75, Issue 4, Page(s) 389–398

Abstract: Lanthanum carbonate is a new phosphate binder that is poorly absorbed from the gastrointestinal tract and eliminated largely by the liver. After oral treatment, we and others had noticed 2-3 fold higher lanthanum levels in the livers of rats with chronic ...

Abstract	Lanthanum carbonate is a new phosphate binder that is poorly absorbed from the gastrointestinal tract and eliminated largely by the liver. After oral treatment, we and others had noticed 2-3 fold higher lanthanum levels in the livers of rats with chronic renal failure compared to rats with normal renal function. Here we studied the kinetics and tissue distribution, absorption, and subcellular localization of lanthanum in the liver using transmission electron microscopy, electron energy loss spectrometry, and X-ray fluorescence. We found that in the liver lanthanum was located in lysosomes and in the biliary canal but not in any other cellular organelles. This suggests that lanthanum is transported and eliminated by the liver via a transcellular, endosomal-lysosomal-biliary canicular transport route. Feeding rats with chronic renal failure orally with lanthanum resulted in a doubling of the liver levels compared to rats with normal renal function, but the serum levels were similar in both animal groups. These levels plateaued after 6 weeks at a concentration below 3 microg/g in both groups. When lanthanum was administered intravenously, thereby bypassing the gastrointestinal tract-portal vein pathway, no difference in liver levels was found between rats with and without renal failure. This suggests that there is an increased gastrointestinal permeability or absorption of oral lanthanum in uremia. Lanthanum levels in the brain and heart fluctuated near its detection limit with long-term treatment (20 weeks) having no effect on organ weight, liver enzyme activities, or liver histology. We suggest that the kinetics of lanthanum in the liver are consistent with a transcellular transport pathway, with higher levels in the liver of uremic rats due to higher intestinal absorption.
MeSH term(s)	Animals ; Bile Canaliculi/metabolism ; Brain/metabolism ; Intestinal Absorption ; Kidney Failure, Chronic/drug therapy ; Lanthanum/administration & dosage ; Lanthanum/pharmacokinetics ; Liver/metabolism ; Lysosomes/metabolism ; Male ; Myocardium/metabolism ; Rats ; Rats, Inbred Strains ; Tissue Distribution ; Uremia/metabolism
Chemical Substances	lanthanum carbonate (490D9F069T) ; Lanthanum (6I3K30563S)
Language	English
Publishing date	2009-02
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	120573-0
ISSN	1523-1755 ; 0085-2538
ISSN (online)	1523-1755
ISSN	0085-2538
DOI	10.1038/ki.2008.571
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 797: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito